To further improve the selective delivery of the formulation to the tumour site, the particles were finally incubated with the anti-VEGF (anti-vascular endothelial growth factor) antibody Avastin®, which was covalently bound to the liposomal surface (Figure 2). Here, VEGFA is linked to neoplasm.